Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
出版年份 2011 全文链接
标题
Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
作者
关键词
-
出版物
ARTHRITIS RESEARCH & THERAPY
Volume 13, Issue 3, Pages R75
出版商
Springer Nature
发表日期
2011-05-14
DOI
10.1186/ar3337
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
- (2010) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: A twenty-four-week clinical trial
- (2010) I.-H. Song et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Monoclonal antibodies and fusion proteins and their complications: Targeting B cells in autoimmune diseases
- (2010) Susan Lee et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
- (2010) R. F. van VOLLENHOVEN et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- The red wolf remains a wily foe
- (2010) Peter E. Lipsky et al. Nature Reviews Rheumatology
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus
- (2010) F. Catapano et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab in ANCA-Associated Disease
- (2010) Ronald J. Falk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Rituximab in Severe Pemphigus
- (2009) Enno Schmidt et al. Annals of the New York Academy of Sciences
- Rituximab fixed retreatment versus on-demand retreatment in refractory rheumatoid arthritis: comparison of two B cell depleting treatment strategies
- (2009) Y K O Teng et al. ANNALS OF THE RHEUMATIC DISEASES
- Incidence, Risk Factors, and Severity of Herpesvirus Infections in a Cohort of 121 Patients With Primary Dermatomyositis and Dermatomyositis Associated With a Malignant Neoplasm
- (2009) Laurence Fardet et al. ARCHIVES OF DERMATOLOGY
- A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis
- (2009) Rachel B. Jones et al. ARTHRITIS AND RHEUMATISM
- A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients
- (2009) Tim Y.-T. Lu et al. ARTHRITIS AND RHEUMATISM
- Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
- (2009) Simon R. J. Taylor et al. ARTHRITIS AND RHEUMATISM
- Rituximab may form a complex with iGmκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virusâinduced vasculitis
- (2009) Damien Sène et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
- (2009) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- B-cell depletion with rituximab for refractory head and neck Wegener’s granulomatosis: a cohort study
- (2009) M. Martinez Del Pero et al. CLINICAL OTOLARYNGOLOGY
- Immunosuppressive disorders and risk of anal squamous cell carcinoma: A nationwide cohort study in Denmark, 1978-2005
- (2009) Kåre G. Sunesen et al. INTERNATIONAL JOURNAL OF CANCER
- Rituximab Mediates a Strong Elevation of B-Cell-Activating Factor Associated with Increased Pathogen-Specific IgG but Not Autoantibodies in Pemphigus Vulgaris
- (2009) Angela Nagel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- B-cell-directed therapies for autoimmune disease
- (2009) Thomas Dörner et al. Nature Reviews Rheumatology
- Recurrence of Wegener's granulomatosis with de novo intraoral presentation treated successfully with rituximab
- (2009) Konrad S. Staines et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS
- Risk factors for major infections in Wegener granulomatosis: analysis of 113 patients
- (2008) C Charlier et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab for Severe Refractory Pediatric Wegener Granulomatosis
- (2008) Aarat M. Patel et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Lack of short-term efficacy of rituximab upon symptoms of ankylosing spondylitis treated for an associated vasculitis
- (2008) Daniel Wendling et al. JOINT BONE SPINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started